Users Coming Off Slimming Jabs Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis reveals that people who come off new GLP-1 drugs like semaglutide or tirzepatide can put back on shed pounds far faster than those who stop traditional lifestyle regimens.

Findings released in a prominent medical journal demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Users buying such drugs need to be cognizant of the risk of rapid rebound weight gain when the medication concludes," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to original weight in about one and a half years.

Analyzing Therapies

The analysis, which examined dozens of trials involving over 9,000 of patients, contrasted the outcomes of GLP-1 agonists with conventional dieting.

Scientists note that people who lose weight through dieting typically see a more gradual weight regain—approximately 0.1 kg a month—post-intervention.

The Reason for the Rapid Rebound

Doctors propose the mechanism of the jabs accounts for the heightened weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication leads to hunger is uncontrolled, making overeating a significant risk."

A Chronic Disease?

Health authorities recommend the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.

Professionals say that, due to the significant potential of relapse, the treatment is often long-term.

This opinion is supported by drug manufacturers, who note that the results "highlight the long-term nature of excess weight," similar to managing conditions like high blood pressure.

User Testimonies

Users who have discontinued the medication report a sudden return of hunger.

"I experienced a switch that goes on and you become starving," recalled a patient.

This challenge is exacerbated if users have not established lasting lifestyle or habit modifications during treatment.

Growing Use

Survey data indicate that a significant number of adults in the UK have used these injections in the last 12 months, with desire being substantial.

• Adoption is more common among women compared to men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion access the medications through private prescriptions rather than public health services.

Finally, experts emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic cure and maintained weight loss hinges on integrated behavioural support.